A new study conducted at Tel Aviv University (TAU) and the Sheba Medical Center reveals how melanoma cancer cells affect their immediate environment to support their needs. The researchers say that the cells form new lymph vessels in the dermis in order to go deeper into the skin and spread through the body. They believe… Read More
A breakthrough study has demonstrated for the first time that long-lasting memories are consolidated in the human brain through communication between the hippocampus and the cerebral cortex during sleep. The researchers also found that by inducing deep-brain stimulation during sleep, they can improve memory consolidation. The unique study, published on June 1, 2023, in the… Read More
In a study conducted at Tel Aviv University (TAU), the protein CKAP5 (cytoskeleton-associated protein) was used for the first time as a therapeutic target for RNA-based nanodrugs. After identifying a genetically unstable mutation resistant to both chemotherapy and immunotherapy in the tissues of ovarian cancer, the researchers targeted these cells with lipid nanoparticles containing RNA… Read More
Many parents who smoke think that they are protecting their children by restricting their smoking to a porch or next to a nearby window. However, a new study from Tel Aviv University (TAU) finds that these strategies do not protect most children from exposure to tobacco smoke. In a study unique to Israel, the research… Read More
Researchers from Tel Aviv University (TAU) have found that dedicated hyperbaric oxygen therapy (HBOT) is much more effective in reducing pain than the drug treatment for patients suffering from fibromyalgia as a result of a traumatic brain injury (TBI). The experiment resulted in the healing of 40% of the patients studied. The comparison was conducted… Read More
Dr. Lior Mayo of TAU’s Shmunis School of Biomedicine and Cancer Research and Sagol School of Neuroscience has been chosen to participate in SPARK TEL AVIV, part of the global SPARK program. The program was created to support academic efforts in translating discoveries into therapeutics that address unmet medical needs. Being chosen for the SPARK… Read More
A team of researchers from Tel Aviv University (TAU) and the Israel Institute for Biological Research have developed an mRNA-based vaccine that is 100% effective against a type of bacteria that is lethal to humans. The study, conducted in an animal model, demonstrated that all treated animals were fully protected against the bacteria. According to… Read More
Researchers at Tel Aviv University (TAU) have identified a new genetic risk factor for the complex eye disease Age-related Macular Degeneration (AMD), a leading cause for loss of eyesight at an advanced age. For the first time, they identified proteins that play a key role in the development and functioning of the tissue affected by… Read More